These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 89124)
41. Pharmacokinetic projections for isoxicam and piroxicam in old and young subjects. Campbell AJ; Ferry DG; Edwards IR Br J Rheumatol; 1985 May; 24(2):176-8. PubMed ID: 3995215 [TBL] [Abstract][Full Text] [Related]
42. Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis. Gaspari F; ViganĂ² G; Locatelli M; Remuzzi G Am J Kidney Dis; 1988 Apr; 11(4):338-42. PubMed ID: 3354570 [TBL] [Abstract][Full Text] [Related]
43. The analgetic properties of piroxicam in animals and correlation with experimentally determined plasma levels. Milne GM; Twomey TM Agents Actions; 1980 Apr; 10(1 Pt 2):31-7. PubMed ID: 7386306 [TBL] [Abstract][Full Text] [Related]
44. Piroxicam--a literature review of new results from laboratory and clinical studies. Ando GA; Lombardino JG Eur J Rheumatol Inflamm; 1983; 6(1):3-23. PubMed ID: 6345166 [TBL] [Abstract][Full Text] [Related]
45. Naproxen-aspirin interactions in man. Segre EJ; Chaplin M; Forchielli E; Runkel R; Sevelius H Clin Pharmacol Ther; 1974 Apr; 15(4):374-9. PubMed ID: 4821440 [No Abstract] [Full Text] [Related]
46. Pharmacokinetics of isoxicam in the elderly. Buchanan WW; Grace EM Am J Med; 1985 Oct; 79(4B):35-7. PubMed ID: 4061466 [TBL] [Abstract][Full Text] [Related]
47. Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers. Ollier C; Faaij RA; Santoni A; Duvauchelle T; van Haard PM; Schoemaker RC; Cohen AF; de Greef R; Burggraaf J Clin Pharmacokinet; 2002; 41 Suppl 2():31-7. PubMed ID: 12383043 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of piroxicam: new aspects. Fenner H Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592 [TBL] [Abstract][Full Text] [Related]
51. [Clinical-pharmacological and pharmacokinetic studies with naproxen]. Boost G Arzneimittelforschung; 1975 Feb; 25(2A):281-7. PubMed ID: 1096900 [TBL] [Abstract][Full Text] [Related]
52. [Pharmacokinetic study of piroxicam in healthy man after administration of a single dose equal to 20 mg, by the oral route]. Fourtillan JB; Dubourg D Therapie; 1983; 38(2):163-70. PubMed ID: 6636023 [No Abstract] [Full Text] [Related]
53. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID. Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187 [TBL] [Abstract][Full Text] [Related]
54. Clinical Pharmacokinetics of indomethacin. Helleberg L Clin Pharmacokinet; 1981; 6(4):245-58. PubMed ID: 7249487 [TBL] [Abstract][Full Text] [Related]
55. The effect of cimetidine on serum concentrations of piroxicam. Mailhot C; Dahl SL; Ward JR Pharmacotherapy; 1986; 6(3):112-7. PubMed ID: 3488542 [TBL] [Abstract][Full Text] [Related]
56. [Piroxicam (Felden)]. Rugstad HE Tidsskr Nor Laegeforen; 1983 Sep; 103(25):1762-3. PubMed ID: 6648913 [No Abstract] [Full Text] [Related]
57. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam. Skjodt NM; Davies NM Clin Pharmacokinet; 1998 Jun; 34(6):421-8. PubMed ID: 9646006 [TBL] [Abstract][Full Text] [Related]